Common Contracts
8 similar Executive Employment Agreement contracts by Cytosorbents Corp
Executive Employment AgreementExecutive Employment Agreement • September 19th, 2023 • Cytosorbents Corp • Surgical & medical instruments & apparatus • New Jersey
This Executive Employment Agreement (the “Employment Agreement” or “Agreement”) is made and entered by and between Kathleen P. Bloch (the “Executive”), and CytoSorbents Medical, Inc., on behalf of itself, its parent CytoSorbents Corporation, and all other affiliates and subsidiaries thereof (collectively, the “Company”), dated as of September 18, 2023.
Executive Employment AgreementExecutive Employment Agreement • July 19th, 2023 • Cytosorbents Corp • Surgical & medical instruments & apparatus • New Jersey
This Executive Employment Agreement (the “Employment Agreement” or “Agreement”) is made and entered by and between Alexander D’Amico (the “Executive”), and CytoSorbents Medical, Inc., on behalf of itself, its parent CytoSorbents Corporation, and all other affiliates and subsidiaries thereof (collectively, the “Company”), effective as of July 10, 2023.
Executive Employment AgreementExecutive Employment Agreement • April 27th, 2020 • Cytosorbents Corp • Surgical & medical instruments & apparatus • New Jersey
This Executive Employment Agreement (the “Employment Agreement” or “Agreement”) is made and entered by and between Efthymios Deliargyris, MD (the “Executive”), and CytoSorbents Medical, Inc., on behalf of itself, its parent CytoSorbents Corporate, and all other affiliates and subsidiaries thereof (collectively, the “Company”), effective as of April 12, 2020.
Amended and Restated Executive Employment AgreementExecutive Employment Agreement • August 5th, 2019 • Cytosorbents Corp • Surgical & medical instruments & apparatus • New Jersey
This Amended and Restated Executive Employment Agreement (the “Employment Agreement” or “Agreement”) is made and entered by and between Kathleen P. Bloch (the “Executive”), and CytoSorbents Medical, Inc., on behalf of itself, its parent CytoSorbents Corporate, and all other affiliates and subsidiaries thereof (collectively, the “Company”), effective as of January 1, 2019.
Amended and Restated Executive Employment AgreementExecutive Employment Agreement • August 5th, 2019 • Cytosorbents Corp • Surgical & medical instruments & apparatus • New Jersey
This Amended and Restated Executive Employment Agreement (the “Employment Agreement” or “Agreement”) is made and entered by and between Dr. Phillip P. Chan (the “Executive”), and CytoSorbents Medical, Inc., on behalf of itself, its parent CytoSorbents Corporate, and all other affiliates and subsidiaries thereof (collectively, the “Company”), effective as of January 1, 2019.
Amended and Restated Executive Employment AgreementExecutive Employment Agreement • August 5th, 2019 • Cytosorbents Corp • Surgical & medical instruments & apparatus • New Jersey
This Amended and Restated Executive Employment Agreement (the “Employment Agreement” or “Agreement”) is made and entered by and between Vincent J. Capponi (the “Executive”), and CytoSorbents Medical, Inc., on behalf of itself, its parent CytoSorbents Corporate, and all other affiliates and subsidiaries thereof (collectively, the “Company”), effective as of January 1, 2019.
Executive Employment AgreementExecutive Employment Agreement • July 15th, 2015 • Cytosorbents Corp • Surgical & medical instruments & apparatus • New Jersey
This Executive Employment Agreement (the “Employment Agreement”) by and between Vincent Capponi (the “Executive”) and CytoSorbents Medical, Inc. (with its parent CytoSorbents Corporate, hereinafter referred to as the “Company”), effective as of January 1, 2015.
Executive Employment AgreementExecutive Employment Agreement • July 15th, 2015 • Cytosorbents Corp • Surgical & medical instruments & apparatus • New Jersey
This Executive Employment Agreement (the “Employment Agreement”) by and between Dr. Phillip P. Chan (the “Executive”) and CytoSorbents Medical, Inc. (with its parent CytoSorbents Corporate, hereinafter referred to as the “Company”), effective as of January 1, 2015.
